Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Dehydroepiandrosterone Reverses Systemic Vascular Remodeling Through the Inhibition of the Akt/GSK3-beta/NFAT Axis
Circulation, 09/18/09
Bonnet S et al. – The authors suggest that the orally available DHEA might be an attractive candidate for the treatment of systemic vascular remodeling, including restenosis, and the authors propose a novel mechanism of action for this important hormone and drug.
Related Articles
Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs . dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency
The Aging Male, 11/13/09
Relevance Score: 84%
Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders
Reproductive BioMedicine Online, 11/24/09
Relevance Score: 83%
Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus. A randomized controlled trial
Annals of Rheumatic Diseases, 11/10/09
Relevance Score: 80%
Today in Physiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Atherosclerosis, 12/04/09
"Tolerance" to Nitroglycerin-induced Preconditioning of the Endothelium: A human in vivo study
Heart And Circulatory Physiology, 12/04/09
Stimulatory effects of arachidonic acid on myosin ATPase activity and contraction of smooth muscle via myosin motor domain
Heart And Circulatory Physiology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


